ENHERTU Discussion – April 10th
On behalf of Daiichi Sankyo, Inc. and AstraZeneca, we cordially invite you to join us for an informative, expert-led discussion exploring the clinical
significance of HER2 expression in eligible patients with mBC.
Date:
April 10, 2024
06:30 PM – 08:00 PM
Pacific Standard Time
Speaker:
Lee Schwartzberg
Chief, Medical Oncology and Hematology and Clinical Professor
Renown Institute for Cancer, University of Nevada, Reno
Location:
Be Steak A
1887 South Bascom Avenue
Campbell, CA 95008
RSVP:
Joyce Lew
(415) 9878862
By: 4/3/2024